A20 upregulated stanniocalcin-1 (STC-1) to restrain the translocation of CRT from mitochondria to the plasma membrane, subsequently impeding antigenic presentation (Fig. 3); however, A20 inhibition potentially enhanced the efficacy of anti-PD-1 blockade in CRC [99]. This evidence concerns the gene STC1 and colorectal carcinoma.